The biosimilars market is witnessing significant growth, driven by the increasing demand for affordable biologic medications and the growing prevalence of chronic diseases. Biosimilars are biological products that are highly like already approved reference products, with no clinically meaningful differences in terms of safety, efficacy, and quality. This article explores the key trends,...